|
| Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Bullion ~ Forex ~ Sports ~ Technology ~ Health ~ Features |
| Lung Cancer ~ Lung Cancer ~ Breast Cancer ~ Heart attack ~ All Health Topics |
|
Home
/ Health News / 2008 / July 2008 / July 21, 2008 New immune-based treatment may restore speech in Alzheimers |
Studying how nitric oxide alters brain function can lead to Alzheimers treatment
Downs syndrome symptoms could be prevented in the womb
Intellect Neurosciences, Inc. Issues Letter to Shareholders From Its Chairman and CEO
How cancer prevention drives aging
For the first time, researchers have found how cellular senescence, the well-known mechanism for preventing cancer, can trigger aging and age-related disease by changing the local tissue environment. ANI
Scientists unveil genes vital to vital to adult heart function
In a study on fruit fly Drosophila, scientists at the Burnham Institute for Medical Research (Burnham) have found that genes involved in embryonic heart development are vital to adult heart function in both fruit flies and humans. ANI
Psychiatric disorders common among college-aged
A new study has revealed that psychiatric disorders appear to be common among 18- to 24-year-olds, with overall rates similar among those attending or not attending college. ANI
A new study into the treatment of Alzheimers disease reports improvement in language abilities using a novel immune-based approach.
Washington, July 21 : A new study into the treatment of Alzheimer's disease reports improvement in language abilities using a novel immune-based approach.
A video accompanying the study documents rapid language improvement within minutes of using this new treatment.
Based on previous research by the same authors, this study focuses on the effect of the anti-tumour necrosis factor-alpha (TNF-alpha) drug, etanercept, on measures of verbal ability.
TNF-alpha, a critical component of the brain's immune system, normally finely regulates the transmission of neural impulses in the brain.
The researchers hypothesize that elevated levels of TNF-alpha in Alzheimer's disease interfere with this regulation.
To reduce elevated TNF-alpha, the researchers utilized a unique perispinal delivery method to administer etanercept.
The new study provides preliminary evidence that the disrupted neural communication seen in Alzheimer's disease may be reversible.
"There are limitations to the data presented; the clinical trial was open label, and not controlled," lead author Edward Tobinick, as saying.
"These caveats notwithstanding, the scientific rationale for the further investigation of anti-TNF-alpha treatment of Alzheimer's disease is compelling. In addition, family members, independent neurologists, and other independent observers have confirmed the clinical, cognitive, and behavioral improvement noted," he added.
Disruption of language function, such as the ability to find words, is a common symptom in advancing Alzheimer's disease, and the new study is one of the first to suggest the possibility of a new therapeutic approach that may address these symptoms.
The study is published in the open access journal BMC Neurology.
ANI
